Rosen Law Firm has initiated class action litigation against Picard Medical, Inc. (PMI) on behalf of investors who acquired securities during the period spanning September 2, 2025 through October 31, 2025. The complaint alleges that company defendants disseminated materially false statements while concealing a coordinated scheme involving social media-driven misinformation, insider equity sales, and artificial trading volume designed to artificially elevate stock valuations.
Investors who purchased PMI securities during the specified window are advised to retain legal counsel promptly to protect their interests in the litigation. The firm notes that class members must establish their eligibility and document their investment activity during the relevant period. Legal representation can assist in evaluating potential recovery options and ensuring compliance with procedural requirements.
The lead plaintiff application deadline has been set for April 13, 2026, establishing a critical timeline for affected investors to take action. Those seeking additional information regarding their potential claims or the litigation process are encouraged to contact qualified securities counsel immediately to avoid missing this deadline.